Please ensure Javascript is enabled for purposes of website accessibility

Should You Be Concerned About mRNA COVID Vaccines?

By Keith Speights and Brian Orelli, PhD - Mar 4, 2021 at 8:31AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The short answer: No.

Two of the COVID-19 vaccines that have received U.S. emergency use authorization (EUA) use messenger RNA (mRNA) technology. Pfizer (PFE 3.00%) and BioNTech (BNTX 1.32%) became the first companies to win authorization for an mRNA vaccine. Moderna (MRNA 0.70%) followed close on their heels. In this Motley Fool Live video, recorded on Feb. 24, 2021, contributors Keith Speights and Brian Orelli answer a viewer's question about whether there are reasons to be concerned about the safety of these new mRNA COVID vaccines.

Keith Speights: You were talking about the messenger RNA technology. One of our viewers, Eldan, mentions correctly that mRNA is a new technology. No long-term studies on side effects have been possible thus far. Any concerns about mRNA?

Brian Orelli: I think we have mRNA in our bodies, right? We produce it every day from our DNA to make proteins in our body. I'm not sure that I'm so worried about the mRNA.

I think the components of the mRNA vaccine, the rest of those things, that those will probably be a bigger concern, and they're probably what people are reacting to when they have reactions to the vaccine. They probably actually reacting to the components of the vaccine, not the mRNA itself.

I'm personally not all that worried, but because it's been tested in 30,000 people, but certainly there could be a one in a million issue. Usually, the long-term side effects are due to long-term exposure to a drug. Like Vioxx or whatever, that wasn't because people were taking Vioxx once and they were immediately having heart problems, it was because they were taking it over a long time because they were taking it for their pain.

I think I'm not so concerned with long-term side effects just because it's a one-and-done or two-and-done treatment. You're not exposed to the components of the vaccine for that long.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
$51.59 (3.00%) $1.50
Moderna, Inc. Stock Quote
Moderna, Inc.
$144.27 (0.70%) $1.01
BioNTech SE Stock Quote
BioNTech SE
$134.04 (1.32%) $1.75

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.